Visagie, M.H. (Michelle Helen); Van den Bout, Jan Iman; Joubert, Annie M.
(Public Library of Science, 2017-04-14)
Clinical trials have revealed that the potential anticancer agent, 2-methoxyestradiol (2ME2)
has limitations due to its low bioavailability. Subsequently, 2ME2 derivatives including (8R,
13S,14S,17S)-2-ethyl-13-methyl- ...